Colonis Pharmaceuticals

Colonis Pharmaceuticals is a specialty pharmaceutical company based in the United Kingdom that focuses on the development and commercialization of medicines for niche markets and unmet clinical needs. The company specializes in the "specials-to-licensed" transition, taking unlicensed formulations and putting them through the rigorous regulatory process to obtain formal marketing authorizations. Their product portfolio primarily targets pediatric and geriatric patient populations who require specific dosage forms, such as oral liquids, that are not readily available from large-scale manufacturers. Colonis operates as a subsidiary of Clinigen, leveraging a global infrastructure to distribute its range of products across therapeutic areas including neurology, cardiology, and endocrinology. By providing licensed alternatives to bespoke formulations, the company enhances patient safety and ensures a consistent supply of essential medications.